Spotlight
Clinical
Blog
Partners
CE
Nevakar spins off ophthalmic-only company Vyluma
A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.
Related Videos
Related Content
